Beijing Konruns Pharmaceutical Co., Ltd.

Beijing Konruns Pharmaceutical Co., Ltd. logo
🇨🇳China
Ownership
Public
Established
2003-09-03
Employees
447
Market Cap
-
Website
http://www.konruns.cn

Kanitinib in Treating Patients With Advanced Solid Tumors

Phase 1
Completed
Conditions
Interventions
First Posted Date
2016-09-27
Last Posted Date
2020-09-03
Lead Sponsor
Beijing Konruns Pharmaceutical Co., Ltd.
Target Recruit Count
9
Registration Number
NCT02916095
Locations
🇨🇳

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing, China

© Copyright 2024. All Rights Reserved by MedPath